NCT01712412View on ClinicalTrials.gov

Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
DyspepsiaFunctional Gastrointestinal Disorders
Interventions
DRUG

IW-9179

DRUG

Placebo

Trial Locations (15)

2650

Antwerp University Hospital, Edegem

3000

UZ Leuven, Leuven

3600

Z.O.L. - Campus St. Jan, Genk

7000

CHU Ambroise Pare, Mons

8310

AZ Sint-Lucas Brugge, Bruges

8800

H. Hartziekenhuis Roselare-Menen vzw, Roeselare

9000

Universitair Ziekenhuis Gent, Ghent

1311 RL

FlevoResearch, Almere Stad

6191 JW

PreCare Trial and Recruitment, Beek

4811 SW

Andromed Breda, Breda

5616GB

Andromed Eindhoven, Eindhoven

9711 SG

Andromed Noord, Groningen

2352 RA

Andromed Leiden, Leiden

6229 HX

Maastricht University Med Ctr, Maastricht

3021 HC

Andromed Rotterdam, Rotterdam

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY

NCT01712412 - Phase 2a Study of IW-9179 to Treat Functional Dyspepsia | Biotech Hunter | Biotech Hunter